Do Protagonist Therapeutics Inc (NASDAQ: PTGX) Fit In A Value Investing Philosophy?
Currently, there are 59.52M common shares owned by the public and among those 56.09M shares have been available to trade. The company’s stock has a 5-day price change of 0.57% and -21.64% over the past three months. PTGX shares are trading -4.61% year to date (YTD), with the 12-month market performance up to 49.13% higher. […]
Growth Story Still Intact For Protagonist Therapeutics Inc (PTGX)
Protagonist Therapeutics Inc (PTGX) concluded trading on Thursday at a closing price of $28.52, with 4.61 million shares of worth about $131.35 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 53.58% during that period and on Thursday, February 01 price saw a gain […]
